FDA NDC Directory · JSON-LD · Markdown

Revlimid

NDC 59572-415 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameLenalidomide
Labeler / ManufacturerCelgene Corporation
Marketing categoryNew Drug Application (innovator) · App NDA021880
Dosage form / routeCAPSULE · ORAL
Active ingredientsLENALIDOMIDE (15 mg/1)
Marketing started20060629
Package count2

External sources

Source: openFDA. Public-domain (CC0).